Sign in

CIK 0001737287 · Non-accelerated filer<br>Smaller reporting company

Allogene Therapeutics, Inc.

Sign in to watch
Ticker
ALLO
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
823562771
Phone
(650) 457-2700
Business address
210 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, 94080
  1. DEFA14A Proxy Proxy Materials
  2. SC TO-C Deal Written Communication Relating to an Issuer
  3. S-8 Other Securities Offered to Employees in Benefit Plans
  4. CT ORDER Other Confidential Order
  5. DEFA14A Proxy Proxy Materials
  6. S-8 Other Securities Offered to Employees in Benefit Plans
  7. DEFA14A Proxy Proxy Materials
  8. S-8 Other Securities Offered to Employees in Benefit Plans
  9. S-3ASR Offering Registration Statement
  10. DEFA14A Proxy Proxy Materials
  11. S-8 Other Securities Offered to Employees in Benefit Plans
  12. S-8 Other Securities Offered to Employees in Benefit Plans
  13. POS462B Other POS462B
  14. POS EX Other Post-effective Amendment
  15. CT ORDER Other Confidential Order
  16. EFFECT Other Notice of Effectiveness
  17. S-1MEF Other S-1MEF
  18. CERT Other Certification
  19. 8-A12B Other Registration of Securities
  20. DRS Other Draft Registration Statement

Page 4 of 5 · 81 filings